228 related articles for article (PubMed ID: 37480103)
1. A scoping review on hyposalivation associated with systemic conditions: the role of physical stimulation in the treatment approaches.
Melo JLMA; Coelho CPES; Nunes FPES; Heller D; Grisi DC; Guimarães MDCM; Dame-Teixeira N
BMC Oral Health; 2023 Jul; 23(1):505. PubMed ID: 37480103
[TBL] [Abstract][Full Text] [Related]
2. Significance and Implications of Patient-reported Xerostomia in Sjögren's Syndrome: Findings From the National Institutes of Health Cohort.
Billings M; Dye BA; Iafolla T; Baer AN; Grisius M; Alevizos I
EBioMedicine; 2016 Oct; 12():270-279. PubMed ID: 27639822
[TBL] [Abstract][Full Text] [Related]
3. Sjögren's syndrome: the diagnostic potential of early oral manifestations preceding hyposalivation/xerostomia.
Mignogna MD; Fedele S; Lo Russo L; Lo Muzio L; Wolff A
J Oral Pathol Med; 2005 Jan; 34(1):1-6. PubMed ID: 15610399
[TBL] [Abstract][Full Text] [Related]
4. Electrolytes in stimulated whole saliva in individuals with hyposalivation of different origins.
Almståhl A; Wikström M
Arch Oral Biol; 2003 May; 48(5):337-44. PubMed ID: 12711377
[TBL] [Abstract][Full Text] [Related]
5. [Xerostomia].
Dreyer NS; Lynggaard CD; Jakobsen KK; Pedersen AML; von Buchwald C; Grønhøj C
Ugeskr Laeger; 2021 Jul; 183(27):. PubMed ID: 34219641
[TBL] [Abstract][Full Text] [Related]
6. Effect of laser acupuncture on salivary flow rate in patients with Sjögren's syndrome.
Cafaro A; Arduino PG; Gambino A; Romagnoli E; Broccoletti R
Lasers Med Sci; 2015 Aug; 30(6):1805-9. PubMed ID: 24820476
[TBL] [Abstract][Full Text] [Related]
7. Minor gland saliva flow rate and proteins in subjects with hyposalivation due to Sjogren's syndrome and radiation therapy.
Eliasson L; Almståhl A; Lingström P; Wikström M; Carlén A
Arch Oral Biol; 2005 Mar; 50(3):293-9. PubMed ID: 15740707
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial to verify the irrigation of salivary glands in relieving xerostomia in patients with Sjögren's syndrome.
Du H; Fu Z; Zhong Y; Yuan Y; Zhao J; Ding X; Li S; Gao S; Zhu Y; Song H; Wu H
Front Immunol; 2022; 13():1039599. PubMed ID: 36439107
[TBL] [Abstract][Full Text] [Related]
9. Low-level laser therapy for xerostomia in primary Sjögren's syndrome: a randomized trial.
Fidelix T; Czapkowski A; Azjen S; Andriolo A; Neto PH; Trevisani V
Clin Rheumatol; 2018 Mar; 37(3):729-736. PubMed ID: 29119483
[TBL] [Abstract][Full Text] [Related]
10. Elucidating the role of hyposalivation and autoimmunity in oral candidiasis.
Billings M; Dye BA; Iafolla T; Grisius M; Alevizos I
Oral Dis; 2017 Apr; 23(3):387-394. PubMed ID: 27998016
[TBL] [Abstract][Full Text] [Related]
11. Clinical management of salivary gland hypofunction in patients with head and neck cancer: a scoping review of physical salivary stimulation methods.
Coelho CPES; de Melo JLMA; Nunes FPES; Guimarães MDCM; Heller D; Grisi DC; Dame-Teixeira N
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Oct; 136(4):442-458. PubMed ID: 37380576
[TBL] [Abstract][Full Text] [Related]
12. Interventions for the management of dry mouth: non-pharmacological interventions.
Furness S; Bryan G; McMillan R; Birchenough S; Worthington HV
Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD009603. PubMed ID: 24006231
[TBL] [Abstract][Full Text] [Related]
13. Sialendoscopy increases saliva secretion and reduces xerostomia up to 60 weeks in Sjögren's syndrome patients: a randomized controlled study.
Karagozoglu KH; Vissink A; Forouzanfar T; de Visscher JGAM; Maarse F; Brand HS; van de Ven PM; Jager DHJ
Rheumatology (Oxford); 2021 Mar; 60(3):1353-1363. PubMed ID: 32949144
[TBL] [Abstract][Full Text] [Related]
14. Salivary gland dysfunction and xerostomia in Sjögren's syndrome.
Jensen SB; Vissink A
Oral Maxillofac Surg Clin North Am; 2014 Feb; 26(1):35-53. PubMed ID: 24287192
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Saxon test for patients with hyposalivation without Sjögren's syndrome.
Ono Minagi H; Yamanaka Y; Sakai T
J Oral Rehabil; 2020 Dec; 47(12):1550-1556. PubMed ID: 32965698
[TBL] [Abstract][Full Text] [Related]
16. A Study on Duration of Effect of Transcutaneous Electrical Nerve Stimulation Therapy on Whole Saliva Flow.
Bhasin N; Reddy S; Nagarajappa AK; Kakkad A
J Contemp Dent Pract; 2015 Jun; 16(6):479-85. PubMed ID: 26323452
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
Rhodus NL; Bereuter J
J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169
[TBL] [Abstract][Full Text] [Related]
18. Evaluation, differential diagnosis, and treatment of xerostomia.
Daniels TE
J Rheumatol Suppl; 2000 Dec; 61():6-10. PubMed ID: 11128701
[TBL] [Abstract][Full Text] [Related]
19. Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations.
von Bültzingslöwen I; Sollecito TP; Fox PC; Daniels T; Jonsson R; Lockhart PB; Wray D; Brennan MT; Carrozzo M; Gandera B; Fujibayashi T; Navazesh M; Rhodus NL; Schiødt M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S57.e1-15. PubMed ID: 17379156
[TBL] [Abstract][Full Text] [Related]
20. Minor salivary glands function is decreased in hyposalivation-related diseases.
Wang Z; Li W; Hong X; Su JZ; Hua H; Peng X; Lv L; Yu GY
Arch Oral Biol; 2016 Sep; 69():63-70. PubMed ID: 27243418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
